Integrated Pharmacotherapy in Endocrine and Metabolic Disorders
Targeted Course | Online

Quick Summary
- Course Opens Soon
- Flexible Hours
- 3 Weeks
- Access to Lectures
- Quiz + Assessment
- Completion Certificate
Course Description
This advanced course offers a clinically integrated approach to understanding, evaluating, and managing endocrine and metabolic disorders through pharmacotherapy. Designed for healthcare professionals, pharmacy students, clinical pharmacists, and practitioners, the course emphasizes evidence-based therapeutic strategies and the application of clinical guidelines to real-world patient scenarios. Participants will learn to critically assess disease states, select appropriate pharmacologic interventions, monitor therapeutic outcomes, and manage complex comorbidities. By integrating basic pathophysiology with therapeutic management, this course prepares clinicians to deliver patient-centered care and optimize therapeutic outcomes in endocrine and metabolic health.
The course is structured into 14 focused topics, each broken down into three subtopics:
(a) Clinical and pathophysiological insights,
(b) Pharmacological management strategies, and
(c) Patient case application.
Learners will not only grasp drug mechanisms and clinical use but also gain skills in individualized therapy planning, monitoring, and interdisciplinary collaboration.
Key Learning Objectives
By the end of this course, scholars will be able to:
- Understand the clinical pathophysiology of major endocrine and metabolic disorders.
- Apply evidence-based pharmacological principles to manage these disorders.
- Evaluate and select appropriate drug therapies based on patient-specific factors.
- Monitor and modify pharmacotherapy to achieve optimal therapeutic outcomes.
- Integrate multidisciplinary approaches for comprehensive patient management.
- Interpret clinical practice guidelines and emerging therapies.
- Analyze and resolve complex case scenarios through critical thinking and therapeutic planning.
CURRICULUM
Designed by Pharmscape’s subject matter experts from clinical practice.
Unit 1: Fundamentals of Endocrinology and Metabolic Pharmacotherapy
Subtopics are visible when open for enrolment.
- Â
Unit 2: Diabetes Mellitus: Comprehensive Management
Subtopics are visible when open for enrolment.
- Â
Unit 3: Thyroid Disorders: Hypothyroidism and Hyperthyroidism
Subtopics are visible when open for enrolment.
- Â
Unit 4: Adrenal Gland Disorders: Addison’s Disease and Cushing’s Syndrome
Subtopics are visible when open for enrolment.
- Â
Unit 5: Polycystic Ovary Syndrome (PCOS) and Endocrine Infertility
Subtopics are visible when open for enrolment.
- Â
Unit 6: Osteoporosis and Calcium Metabolic Disorders
Subtopics are visible when open for enrolment.
- Â
Unit 7: Dyslipidemia: Endocrine and Metabolic Perspectives
Subtopics are visible when open for enrolment.
- Â
Unit 8: Obesity and Pharmacologic Weight Management
Subtopics are visible when open for enrolment.
- Â
Unit 9: Pituitary Gland Disorders
Subtopics are visible when open for enrolment.
- Â
Unit 10: Growth Disorders: Short Stature and Acromegaly
Subtopics are visible when open for enrolment.
- Â
Unit 11: Hypercalcemia and Hypocalcemia
Subtopics are visible when open for enrolment.
- Â
Unit 12: Rare Endocrine Disorders: Pheochromocytoma, Multiple Endocrine Neoplasia (MEN)
Subtopics are visible when open for enrolment.
- Â
Unit 13: Endocrine Disorders in Special Populations: Pregnancy and Elderly
Subtopics are visible when open for enrolment.
- Â
Unit 14: Integrated Case Discussions and Therapeutic Planning
Subtopics are visible when open for enrolment.
- Â